AbbVie (ABBV) is a publicly traded Healthcare sector company. As of June 5, 2026, ABBV trades at $224.94 with a market cap of $383.62B and a P/E ratio of 110.08. ABBV moved +3.60% today. Year to date, ABBV is -1.91%; over the trailing twelve months it is +20.07%. Its 52-week range spans $163.81 to $244.81. Analyst consensus is strong buy with an average price target of $255.22. Rallies surfaces ABBV's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
AbbVie (ABBV) research on Rallies includes live charts, financials, analyst ratings, hedge fund holdings, politician trades, insider activity, news, AI research, and community context. ABBV moved +3.60% today. Analyst consensus is strong buy.
| Metric | Value |
|---|---|
| Price | $224.94 |
| Market Cap | $383.62B |
| P/E Ratio | 110.08 |
| EPS | $2.03 |
| Dividend Yield | 1.73% |
| 52-Week High | $244.81 |
| 52-Week Low | $163.81 |
| Volume | 0 |
| Avg Volume | 0 |
| Revenue (TTM) | $62.82B |
| Net Income | $3.64B |
| Gross Margin | 70.68% |
20 analysts cover ABBV: 0 strong buy, 16 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $255.22.